Consensus Laboratorios Farmaceuticos Rovi, S.A.

Equities

Market Closed - BME Other stock markets 11:35:26 2024-04-26 am EDT			5-day change	1st Jan Change
85 ^EUR	+0.35%		+7.05%	+41.20%

Apr. 02	Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment	MT
Mar. 12	Rovi, Partners to Form Entity for Advanced Therapies R&D	MT

28888fb182.yefMQOJoeK2gPoyVJ9Xu-RyBNFa95PmVUmk64kabSaI._IaGBK1dCuzYbMrNEaCqyFrMYmCJ08v6JABulzbaMeW5ioMChgICwfMO3Q~4a5d65996432bd642d7619551f570287

22-02-23

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

85 EUR

Average target price

84.1 EUR

Spread / Average Target

-1.06%

High Price Target

100 EUR

Spread / Highest target

+17.65%

Low Price Target

66 EUR

Spread / Lowest Target

-22.35%

Trading Rating

Investor Rating

ESG Refinitiv

B+